Taruna today launched a new whitepaper proposing how the Taruna model can benefit MedTech companies.…
Taruna today launched a new whitepaper discussing the need for a new commercial model within MedTech.
MedTech, like so many other markets, begins 2021 in a challenging position. This whitepaper explores what these challenges are, and how a new commercial model may allow forward thinking companies to thrive despite the challenging circumstances.
With input from market reports by leading market authorities and commentators including Deloitte, Boston Group Consulting and The New York Times, as well as practical examples, the paper proposes how a new model should look to support MedTech companies.
The paper can be downloaded by clicking here